UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

The Lancet (British edition), 2012-12, Vol.380 (9858), p.2007-2017

2012

Volltextzugriff (PDF)

Effects of Evolocumab (AMG 145), a Monoclonal Antibody to PCSK9, in Hypercholesterolemic, Statin-Treated Japanese Patients at High Cardiovascular Risk: Primary Results From the Phase 2 YUKAWA Study

Circulation Journal, 2014, Vol.78(5), pp.1073-1082

2014

Volltextzugriff (PDF)

AMG145, a Monoclonal Antibody Against Proprotein Convertase Subtilisin Kexin Type 9, Significantly Reduces Lipoprotein(a) in Hypercholesterolemic Patients Receiving Statin Therapy: An Analysis From the LDL-C Assessment With Proprotein Convertase Subtilisin Kexin Type 9 Monoclonal Antibody Inhibition Combined With Statin Therapy (LAPLACE)–Thrombolysis in Myocardial Infarction (TIMI) 57 Trial

Circulation (New York, N.Y.), 2013-08, Vol.128 (9), p.962-969

2013

Volltextzugriff (PDF)

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

Journal of the American College of Cardiology, 2014-04, Vol.63 (13), p.1278-1288

2014

Volltextzugriff (PDF)

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

The New England journal of medicine, 2010-09, Vol.363 (12), p.1146-1155

2010

Volltextzugriff (PDF)

FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death

Cell, 2003-06, Vol.113 (7), p.829-840

2003

Volltextzugriff (PDF)

Analysis of Calstabin2 (FKBP12.6)-Ryanodine Receptor Interactions: Rescue of Heart Failure by Calstabin2 in Mice

Proceedings of the National Academy of Sciences - PNAS, 2006-02, Vol.103 (9), p.3456-3461

2006

Volltextzugriff (PDF)

FKBP12 Binding Modulates Ryanodine Receptor Channel Gating

The Journal of biological chemistry, 2001-05, Vol.276 (20), p.16931-16935

2001

Volltextzugriff (PDF)

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145): A Pooled Analysis of More Than 1,300 Patients in 4 Phase II Trials

Journal of the American College of Cardiology, 2014-04, Vol.63 (13), p.1278-1288

2014

Volltextzugriff (PDF)

HIV/AIDS Behavioral Surveillance among Angolan Military Men

AIDS and behavior, 2008-07, Vol.12 (4), p.578-584

2008

Volltextzugriff (PDF)

Immunophilins and coupled gating of ryanodine receptors

Current topics in medicinal chemistry, 2003-01, Vol.3 (12), p.1383-1391

2003

Volltextzugriff (PDF)

Immunity in Chimpanzees Chronically Infected with Hepatitis C Virus: Role of Minor Quasispecies in Reinfection

Journal of Virology, 1998-03, Vol.72 (3), p.1725-1730

1998

Volltextzugriff (PDF)

PKA Phosphorylation Activates the Calcium Release Channel (Ryanodine Receptor) in Skeletal Muscle: Defective Regulation in Heart Failure

The Journal of cell biology, 2003-03, Vol.160 (6), p.919-928

2003

Volltextzugriff (PDF)

Design and Rationale of the LAPLACE‐TIMI 57 Trial: A Phase II, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy

Clinical cardiology (Mahwah, N.J.), 2012-07, Vol.35 (7), p.385-391

2012

Volltextzugriff (PDF)

PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle

The Journal of cell biology, 2003-03, Vol.160 (6), p.919-928

2003

Volltextzugriff (PDF)

Ryanodine receptor modulation by calstabin2 (FKBP12.6): Structural dynamics and functional implications

Huang, Fannie

2006

Volltextzugriff (PDF)

Empirical methods to calculate an erythropoiesis-stimulating agent dose conversion ratio in nondialyzed patients with chronic kidney disease

Journal of managed care pharmacy, 2009-11, Vol.15 (9), p.741-750

2009

Volltextzugriff (PDF)

How do training experience and geographical origin of a runner affect running biomechanics?

Gait & posture, 2021-02, Vol.84, p.209-214

2021

Volltextzugriff (PDF)

Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)

Pain practice, 2018-02, Vol.18 (2), p.230-238

2018

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)
Dissertationen
(1)

Sprache

Englisch
(19)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study

Effects of Evolocumab (AMG 145), a Monoclonal Antibody to PCSK9, in Hypercholesterolemic, Statin-Treated Japanese Patients at High Cardiovascular Risk: Primary Results From the Phase 2 YUKAWA Study

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145)

Erythropoietic Response and Outcomes in Kidney Disease and Type 2 Diabetes

FKBP12.6 Deficiency and Defective Calcium Release Channel (Ryanodine Receptor) Function Linked to Exercise-Induced Sudden Cardiac Death

Analysis of Calstabin2 (FKBP12.6)-Ryanodine Receptor Interactions: Rescue of Heart Failure by Calstabin2 in Mice

FKBP12 Binding Modulates Ryanodine Receptor Channel Gating

Reduction in Lipoprotein(a) With PCSK9 Monoclonal Antibody Evolocumab (AMG 145): A Pooled Analysis of More Than 1,300 Patients in 4 Phase II Trials

HIV/AIDS Behavioral Surveillance among Angolan Military Men

Immunophilins and coupled gating of ryanodine receptors

Immunity in Chimpanzees Chronically Infected with Hepatitis C Virus: Role of Minor Quasispecies in Reinfection

PKA Phosphorylation Activates the Calcium Release Channel (Ryanodine Receptor) in Skeletal Muscle: Defective Regulation in Heart Failure

Design and Rationale of the LAPLACE‐TIMI 57 Trial: A Phase II, Double‐Blind, Placebo‐Controlled Study of the Efficacy and Tolerability of a Monoclonal Antibody Inhibitor of PCSK9 in Subjects With Hypercholesterolemia on Background Statin Therapy

PKA phosphorylation activates the calcium release channel (ryanodine receptor) in skeletal muscle

Ryanodine receptor modulation by calstabin2 (FKBP12.6): Structural dynamics and functional implications

Empirical methods to calculate an erythropoiesis-stimulating agent dose conversion ratio in nondialyzed patients with chronic kidney disease

How do training experience and geographical origin of a runner affect running biomechanics?

Effectiveness and Safety of Intrathecal Ziconotide: Interim Analysis of the Patient Registry of Intrathecal Ziconotide Management (PRIZM)

Suchergebnisse filtern